CHSS: Tricuspid Atresia

March 15, 2019

Congenital Heart Surgeons’ Society Studies in Congenital Heart Disease: Tricuspid Atresia

  • Clinical Trial Information

    Trial Contact: McKinney, Nanette

    Trial Phone: 321-835-7715

  • IRB No: 18.152.11

    Protocol Abbrev: TA

    Principal Investigator: William M. DeCampli, MD

    Age Group: Pediatric

  • Objective

    A. The overall goal of this study is to assemble a multi-institutional inception cohort of patients with Tricuspid Atresia and normally related great arteries.

    B. The overall objectives of this study are:

    (a) to determine the impact of patient characteristics and management algorithms on outcomes for infants with TA and normally related great arteries

    (b) to determine the overall Functional Health Status (FHS) and Quality of Life (QOL) of patients with TA and normally related great arteries

  • Key Eligibility

    - Diagnosis of Tricuspid Atresia with normally related great arteries
    - Age < 3 months at time of diagnosis
    - Admitted to a CHSS institution on or after January 1, 1999; i.e., Date of Birth on or after October 1, 1998